Age-related macular degeneration (AMD) and digital eye strain are driving demand for eye supplements. The AREDS2 formulation remains the clinical gold standard for slowing intermediate AMD progression.
- Lutein (10 mg) + Zeaxanthin (2 mg): The AREDS2 dosing. Macular pigment optical density improvement is well-documented.
- Vitamin C (500 mg), Vitamin E (400 IU), Zinc (80 mg or 25 mg low-dose version): Antioxidant stack from AREDS2.
- Omega-3 DHA (250β500 mg/day): Retinal structural component. Supports dry eye symptoms.
- Bilberry extract (80β160 mg standardized to 25% anthocyanins): Small RCTs show modest benefits for night vision.
- Astaxanthin (4β12 mg/day): Crosses blood-retinal barrier; may reduce eye fatigue in screen workers.
- Products claiming to reverse cataracts or glaucoma β these require medical intervention
- Underdosed lutein/zeaxanthin (< 10 mg and 2 mg respectively)
- Vitamin A at high doses without ophthalmologist oversight β risk in smokers
AREDS2-matching formulas score highest for AMD prevention. For digital eye strain and general eye health, we prioritize lutein/zeaxanthin ratio, astaxanthin inclusion, and omega-3 content.